| 2022-11-23 | Sale | Denali Therapeutics Inc. DNLI | director | 20,000 0.0151% | $30.48 | $609,600 | -12.23% | |
| 2022-11-02 | Sale | Denali Therapeutics Inc. DNLI | director | 11,252 0.0084% | $30.33 | $341,273 | -10.06% | |
| 2022-11-01 | Sale | Denali Therapeutics Inc. DNLI | director | 8,748 0.0069% | $30.20 | $264,190 | -4.47% | |
| 2022-09-29 | Sale | Regeneron Pharmaceuticals, Inc. REGN | 160 0.0002% | $697.29 | $111,566 | +8.42% | ||
| 2022-09-28 | Sale | Denali Therapeutics Inc. DNLI | 4,423 0.0035% | $31.08 | $137,467 | -11.63% | ||
| 2022-08-23 | Sale | Denali Therapeutics Inc. DNLI | 100 <0.0001% | $32.43 | $3,243 | -9.56% | ||
| 2022-07-25 | Sale | Denali Therapeutics Inc. DNLI | 200 0.0002% | $36.15 | $7,230 | -16.98% | ||
| 2022-03-23 | Sale | Denali Therapeutics Inc. DNLI | director | 20,000 0.0165% | $33.83 | $676,583 | -11.97% | |
| 2022-03-21 | Sale | Regeneron Pharmaceuticals, Inc. REGN | 7,439 0.0069% | $690.00 | $5.13M | +2.41% | ||
| 2022-03-16 | Sale | Regeneron Pharmaceuticals, Inc. REGN | 4,361 0.0041% | $675.00 | $2.94M | +4.48% | ||
| 2021-12-30 | Sale | Denali Therapeutics Inc. DNLI | director | 20,047 0.0165% | $45.36 | $909,361 | -31.37% | |
| 2021-12-29 | Sale | Denali Therapeutics Inc. DNLI | director | 32,104 0.0262% | $43.88 | $1.41M | -29.79% | |
| 2021-12-28 | Sale | Denali Therapeutics Inc. DNLI | director | 10,980 0.009% | $44.37 | $487,219 | -30.16% | |
| 2021-12-09 | Sale | Regeneron Pharmaceuticals, Inc. REGN | director | 3,784 0.0036% | $665.00 | $2.52M | -3.8% | |
| 2021-09-13 | Sale | Regeneron Pharmaceuticals, Inc. REGN | director | 12,750 0.012% | $641.71 | $8.18M | -2.6% | |
| 2021-06-07 | Sale | Denali Therapeutics Inc. DNLI | director | 94,378 0.0762% | $70.35 | $6.64M | -37.07% | |
| 2021-05-24 | Sale | Denali Therapeutics Inc. DNLI | director | 8,806 0.0071% | $60.02 | $528,580 | -24.99% | |
| 2021-05-21 | Sale | Denali Therapeutics Inc. DNLI | director | 37,957 0.0319% | $60.13 | $2.28M | -21.54% | |
| 2021-05-03 | Sale | Denali Therapeutics Inc. DNLI | director | 3,237 0.0028% | $60.11 | $194,589 | -18.02% | |
| 2021-04-01 | Sale | Denali Therapeutics Inc. DNLI | director | 50,000 0.0417% | $56.62 | $2.83M | -9.03% |